TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,061
|
2,700
|
3,245 |
| Financial expenses |
62
|
35
|
22 |
| Earnings before taxes |
-958
|
-2,736
|
-766 |
| EBITDA |
-98
|
-806
|
22 |
| Total assets |
4,379
|
5,934
|
8,634 |
| Current assets |
1,610
|
2,356
|
4,083 |
| Current liabilities |
1,235
|
1,309
|
1,422 |
| Equity capital |
2,883
|
3,969
|
6,682 |
| - share capital |
321
|
333
|
332 |
| Employees (average) |
20
|
23
|
22 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
65.8%
|
66.9%
|
77.4% |
| Turnover per employee |
153
|
117
|
148 |
| Profit as a percentage of turnover |
-31.3%
|
-101.3%
|
-23.6% |
| Return on assets (ROA) |
-20.5%
|
-45.5%
|
-8.6% |
| Current ratio |
130.4%
|
180.0%
|
287.1% |
| Return on equity (ROE) |
-33.2%
|
-68.9%
|
-11.5% |
| Change turnover |
452
|
-555
|
711 |
| Change turnover % |
17%
|
-17%
|
28% |
| Chg. No. of employees |
-3
|
1
|
-2 |
| Chg. No. of employees % |
-13%
|
5%
|
-8% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.